This public procurement contract is for the supply of scanners necessary for the complete digitization of the biopsy operations at the Oncology Pathology Department of the contracting authority. The specifications and conditions are outlined in Appendix 2 of the tender documentation (contract templa
Tender closed on 17 Oct 2025. Awaiting award.
This public procurement contract involves the supply of medicinal products as specified in the attached documents. The contract is divided into five parts according to the specifications provided in the documentation. Suppliers are invited to submit their offers based on the detailed requirements ou
This public procurement contract involves the supply of a theragnostic application system, including necessary accessories and related consumables as specified in Appendix 2 of the tender documentation (contract templates). Additionally, it includes the provision of related supplies and services as
This public procurement contract is for the supply of a genetic analyzer specifically designed for Sanger sequencing and fragment analysis. It includes the provision of related consumables as specified in the relevant appendices of the tender documentation. Suppliers are invited to submit their prop
This public procurement contract involves the supply of a medicinal product, specifically Fludeoxyglucose-(18F), as detailed in the specifications and conditions outlined in attachments 2 (Public Procurement Specifications) and 3 (Sample Purchase Agreement) of the tender documentation. The contract
Ireland is seeking a qualified occupational health services provider to deliver comprehensive workplace health assessments, medical surveillance, and occupational health advisory services.
NHSBT seeks suppliers of colour-coded EDTA sample tubes with bar-code labels to support testing of 1.5 million annual blood and tissue donations across two English facilities.
BHRUT seeks an outsourced dermatology service provider to treat 800 waiting list patients from November 2026 to March 2027 (£520,000 contract value).
A competitive NHS framework agreement enabling the supply of unlicensed imported medicines to healthcare organisations and eligible public bodies, subject to strict regulatory compliance and quality assurance standards.
